Two Sigma Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-85,200
Closed -$2.32M 58
2025
Q4
$2.32M Buy
85,200
+71,600
+526% +$2.51M ﹤0.01% 1122
2025
Q3
$546K Buy
+13,600
New +$512K ﹤0.01% 1730
2025
Q1
Sell
-22,200
Closed -$729K 2368
2024
Q4
$729K Buy
+22,200
New +$1.04M ﹤0.01% 1613
2024
Q2
Sell
-20,900
Closed -$611K 2422
2024
Q1
$611K Buy
+20,900
New +$560K ﹤0.01% 1786
2022
Q1
Sell
-6,400
Closed -$210K 2719
2021
Q4
$210K Buy
+6,400
New +$258K ﹤0.01% 2275
2021
Q2
Sell
-16,500
Closed -$852K 2430
2021
Q1
$852K Buy
+16,500
New +$817K ﹤0.01% 1737
2020
Q4
Sell
-38,200
Closed -$1.34M 2366
2020
Q3
$1.34M Buy
+38,200
New +$1.67M ﹤0.01% 1369
2020
Q1
Sell
-35,100
Closed -$1.68M 2445
2019
Q4
$1.68M Buy
+35,100
New +$1.33M ﹤0.01% 1313
2019
Q3
Sell
-5,400
Closed -$269K 2207
2019
Q2
$269K Buy
+5,400
New +$289K ﹤0.01% 2048
2019
Q1
Sell
-34,200
Closed -$1.58M 2284
2018
Q4
$1.58M Buy
34,200
+7,300
+27% +$451K ﹤0.01% 1292
2018
Q3
$2.08M Sell
26,900
-43,500
-62% -$3.5M 0.01% 1214
2018
Q2
$5.93M Sell
70,400
-21,900
-24% -$1.91M 0.02% 783
2018
Q1
$7.55M Sell
92,300
-14,500
-14% -$1.12M 0.02% 693
2017
Q4
$6.11M Buy
106,800
+64,200
+151% +$4.04M 0.02% 782
2017
Q3
$2.84M Buy
42,600
+200
+0.5% +$12K 0.01% 1042
2017
Q2
$2.18M Buy
42,400
+5,200
+14% +$266K 0.01% 1158
2017
Q1
$2.17M Buy
37,200
+4,900
+15% +$235K 0.01% 1214
2016
Q4
$1.35M Buy
32,300
+18,300
+131% +$960K 0.01% 1392
2016
Q3
$739K Buy
+14,000
New +$610K ﹤0.01% 1493

Other funds holding AGIO